Levin Capital Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Whirlpool
WHR
|
+$117M |
| 2 |
GE Aerospace
GE
|
+$90.3M |
| 3 |
Macy's
M
|
+$76.1M |
| 4 |
Hewlett Packard
HPE
|
+$75.5M |
| 5 |
HES
Hess
HES
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$102M |
| 2 |
Cigna
CI
|
+$88M |
| 3 |
Target
TGT
|
+$84.9M |
| 4 |
KKR & Co
KKR
|
+$57.2M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$48.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.97% |
| 2 | Technology | 16.82% |
| 3 | Healthcare | 10.86% |
| 4 | Materials | 10.41% |
| 5 | Industrials | 9.72% |
Similar funds
Levin Capital Strategies's Q1 2017 Portfolio in Review
As of Q1 2017, Levin Capital Strategies held 360 positions worth $5.61B, down 3.7% from $5.82B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Levin Capital Strategies withdrew a net $399M in Q1 2017, closing 57 positions and reducing 99 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $48.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Levin Capital Strategies opened a new position in Whirlpool worth $113M.
- Levin Capital Strategies's largest Q1 2017 buy was Whirlpool: 660,286 shares worth $113M.
- Levin Capital Strategies added most to GE Aerospace in Q1 2017, an estimated $90.3M increase.
- Levin Capital Strategies's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $102M.
- Levin Capital Strategies fully exited Bio-Rad Laboratories Class A in Q1 2017, selling an estimated $48.8M.
- Levin Capital Strategies's ten largest holdings make up 41% of its $5.61B portfolio in Q1 2017.
- Levin Capital Strategies opened 57 new positions and closed 57 in Q1 2017.
- Levin Capital Strategies's portfolio value fell 3.7% quarter-over-quarter to $5.61B.
Based on Levin Capital Strategies's 13F filing for Q1 2017, filed 9 May 2017.